(Q40542932)

21 September 2017

Regional NAD(P)H:quinone oxidoreductase activity in Alzheimer's disease (English)

1 reference

21 September 2017

5

Charles DeCarli

0 references

author name string

Karen S SantaCruz

1

1 reference

21 September 2017

Eugenia Yazlovitskaya

2

1 reference

21 September 2017

Julie Collins

3

1 reference

21 September 2017

Jeff Johnson

4

1 reference

21 September 2017

1 January 2004

1 reference

21 September 2017

Neurobiology of Aging

1 reference

21 September 2017

25

1 reference

21 September 2017

1

1 reference

21 September 2017

63-69

1 reference

Parkinson's disease--redox mechanisms

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900117-9

7 January 2021

The expression of key oxidative stress-handling genes in different brain regions in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900117-9

7 January 2021

Staging of Alzheimer's disease-related neurofibrillary changes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900117-9

7 January 2021

Diagnostic criteria for neuropathologic assessment of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900117-9

7 January 2021

Evolution of neuronal changes in the course of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900117-9

7 January 2021

Evolution of Alzheimer's disease related cortical lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900117-9

7 January 2021

DT-diaphorase-catalyzed two-electron reduction of quinone epoxides

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900117-9

7 January 2021

Activation of endogenous antioxidant defenses in neuronal cells prevents free radical-mediated damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900117-9

7 January 2021

Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900117-9

7 January 2021

Staurosporine and K-252 compounds protect hippocampal neurons against amyloid beta-peptide toxicity and oxidative injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900117-9

7 January 2021

Reactive oxygen species as causal agents in the neurotoxicity of the Alzheimer's disease-associated amyloid beta peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900117-9

7 January 2021

Oxidative stress and the pathogenesis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900117-9

7 January 2021

Activation of the antioxidant response element in primary cortical neuronal cultures derived from transgenic reporter mice

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900117-9

7 January 2021

The antioxidant enzyme quinone reductase is up-regulated in vivo following cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900117-9

7 January 2021

Microarray analysis reveals an antioxidant responsive element-driven gene set involved in conferring protection from an oxidative stress-induced apoptosis in IMR-32 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900117-9

7 January 2021

Metabolism of benzo(a)pyrene-3,6-quinone and 3-hydroxybenzo(a)pyrene in liver microsomes from 3-methylcholanthrene-treated rats. A possible role of DT-diaphorase in the formation of glucuronyl conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900117-9

7 January 2021

Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900117-9

7 January 2021

Oxidative stress hypothesis in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900117-9

7 January 2021

The role of oxidative stress in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900117-9

7 January 2021

Oxidative alterations in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900117-9

7 January 2021

Preferential expression of antioxidant response element mediated gene expression in astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900117-9

7 January 2021

The progression of Alzheimer's disease from limbic regions to the neocortex: clinical, radiological and pathological relationships.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900117-9

7 January 2021

Quinone reductase (NQO1), a sensitive redox indicator, is increased in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900117-9

7 January 2021

NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900117-9

7 January 2021

Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900117-9

7 January 2021

Reduction of H2O2-evoked, intracellular calcium increases in the rat N18-RE-105 neuronal cell line by pretreatment with an electrophilic antioxidant inducer

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900117-9

7 January 2021

GADD45 is induced in Alzheimer's disease, and protects against apoptosis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900117-9

7 January 2021

Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase).

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900117-9

7 January 2021

NAD(P)H:quinone oxidoreductase activity is increased in hippocampal pyramidal neurons of patients with Aalzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900117-9

7 January 2021

10.1016/S0197-4580(03)00117-9

Identifiers

DOI

1 reference

21 September 2017

1 reference